Virtus ETF Advisers’s SpringWorks Therapeutics SWTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,037	Closed	-$327K	–	757
2024 Q4	$327K	Buy	9,037 +622	+7%	+$21.7K	0.13%	232
2024 Q3	$270K	Hold	8,415	–	–	0.13%	238
2024 Q2	$317K	Sell	8,415 -2,572	-23%	-$108K	0.16%	220
2024 Q1	$541K	Buy	10,987 +1,581	+17%	+$73.1K	0.29%	169
2023 Q4	$343K	Buy	9,406 +5,816	+162%	+$152K	0.22%	193
2023 Q3	$83K	Sell	3,590 -356	-9%	-$9.73K	0.05%	354
2023 Q2	$103K	Sell	3,946 -368	-9%	-$9.67K	0.06%	366
2023 Q1	$111K	Sell	4,314 -1,664	-28%	-$48.6K	0.06%	330
2022 Q4	$155K	Buy	5,978 +827	+16%	+$20.4K	0.08%	334
2022 Q3	$147K	Buy	5,151 +40	+0.8%	+$1.15K	0.06%	355
2022 Q2	$126K	Buy	5,111 +2,823	+123%	+$103K	0.05%	368
2022 Q1	$129K	Sell	2,288 -137	-6%	-$7.84K	0.06%	250
2021 Q4	$150K	Sell	2,425 -215	-8%	-$14.2K	0.06%	348
2021 Q3	$167K	Sell	2,640 -134	-5%	-$10.3K	0.07%	317
2021 Q2	$229K	Sell	2,774 -1,232	-31%	-$93.5K	0.09%	244
2021 Q1	$295K	Buy	4,006 +66	+2%	+$5.17K	0.12%	243
2020 Q4	$286K	Sell	3,940 -3,228	-45%	-$208K	0.12%	232
2020 Q3	$342K	Sell	7,168 -981	-12%	-$41.8K	0.18%	193
2020 Q2	$342K	Sell	8,149 -4,299	-35%	-$153K	0.16%	273
2020 Q1	$336K	Sell	12,448 -1,805	-13%	-$58.8K	0.14%	214
2019 Q4	$549K	Buy	+14,253	New	+$334K	0.09%	198